Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of metallothionein-1 in preparation of medicine for treating bacterial infection

A technology for bacterial infection and inhibition of bacteria, applied in antibacterial drugs, pharmaceutical formulations, medical preparations containing active ingredients, etc., can solve the problems of escaping antibiotic inhibition and killing, and achieve the effect of reducing mortality

Active Publication Date: 2021-12-31
黄钟
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to nearly a hundred years of application, although we have made rapid progress in the discovery and manufacture of antibiotics, many bacteria have gradually escaped the inhibition and killing of antibiotics through their evolution, especially the abuse of antibiotics, and the number of drug-resistant bacteria is increasing. , rendering the antibiotics we currently have ineffective against many bacteria

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of metallothionein-1 in preparation of medicine for treating bacterial infection
  • Application of metallothionein-1 in preparation of medicine for treating bacterial infection
  • Application of metallothionein-1 in preparation of medicine for treating bacterial infection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Example 1 LM infection of HepG2 cells significantly induced the expression of inflammatory cytokines and MT1a

[0041] Overexpression of metallothionein-1 and recombinant proteins inhibit inflammation in autoimmune diseases, promote the differentiation of regulatory T cells and reduce the expression of innate and acquired immune inflammatory factors, suggesting that the expression of metallothionein is inhibited and metallothionein is down-regulated Protein levels can be upregulated by mechanisms of immunity. Small molecule protein MT is widely involved in heavy metal detoxification and free radical scavenging, and studies have shown that MT protein has immune regulation function. In order to study the role of MT in LM infection, the effect of LM infection on the expression of MT in hepatocytes was first analyzed (hepatocytes have been shown to highly express MT).

[0042] We learned from GEPIA database and Human Protein Atlas that Mt1a, Mt1h, and Mt2a are highly expre...

Embodiment 2

[0082] Example 2 Knocking out the MT1 gene reduces the bacterial load of LM in mouse liver and spleen

[0083] MT1 is rich in Cys, which can maintain the level of intracellular heavy metals, especially zinc ions, through the combination and release of sulfhydryl groups and zinc ions, and remove active oxygen through redox cycles; down-regulating the expression of MT1 will reduce intracellular zinc ions and increase intracellular activity The level of free radicals such as oxygen, while zinc ions are essential nutrients for the proliferation of LM and many bacteria, free radicals have a killing effect on LM. In recent years, metallothionein has emerged as an important, but largely underappreciated component of the immune system. MTs have been shown to participate in the regulation of innate and adaptive immunity through the regulation of heavy metal ions and redox status in immune cells, as well as through the regulation of various immune-related cytokines and transcripts. Inc...

Embodiment 3

[0207] Example 3 Knocking out the MT1 gene reduces the lethality of Listeria monocytogenes-infected mice

[0208] One, experimental material and reagent are identical with embodiment 2;

[0209] 2. Experimental method:

[0210] 1. The establishment of the systemic infection model of Listeria monocytogenes live bacteria is the same as in Example 2;

[0211] 2. Live Listeria monocytogenes infection of MT1 - / - After mixing with WT mice, the body weight of the mice was recorded every day, and the symptoms and signs of the mice and whether they died were observed.

[0212] 3. Experimental results

[0213] 1. Knocking out the MT1 gene reduces the weight loss of mice caused by LM infection

[0214] To further study MT1 - / - In the role of LM infection, this embodiment uses 6.5x10 5 cfu LM infection of WT mice and Mt1 - / - After 60 hours of the mice, the body weight changes of the mice were observed. The results showed that in LM-infected mice, compared with wild-type mice, MT1 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of metallothionein-1 in preparation of a medicine for treating bacterial infection and belongs to the field of biological pharmacy. The invention discloses the application of the MT-1 as an action target in preparation of the medicine for treating the bacterial infection. Bacterial inhibiting and killing effects are achieved through MT-1 knockout, MT-siRNA silence and MT transcription regulation; and experimental results show that by blocking the expression of metallothionein, the loading quantity of Listeria monocytogenes and the gene level of bacterial virulence factors of the liver and spleen of an infected mouse can be remarkably reduced, general and histological pathological changes of the liver and spleen of the mouse are remarkably relieved, and the death rate of experimental animals is greatly reduced; and according to the research, the metallothionein is taken as the target, so that a clinical treatment basis is provided for treatment of monocyte-proliferation Listeria monocytogenes infection and related-bacterium infection, especially severe infection of drug-resistant bacteria and septicemia.

Description

technical field [0001] The invention relates to the field of biopharmaceuticals, in particular to the application of metallothionein-1 in the preparation of medicines for treating bacterial infections. Background technique [0002] Metallothionein (MT) is a group of cysteine-rich proteins that can be induced by stress, heavy metals, cytokines, reactive oxygen species and microbial infection. Its main function is to regulate intracellular redox state by scavenging reactive oxygen species and regulating intracellular levels of heavy metals, especially zinc ions, through the chelation and release of intracellular heavy metals, especially zinc ions, and then participate in the activities mediated by them. Signaling pathways involved in immune regulation. Results from our and other laboratories have shown that overexpression of metallothionein 1 and recombinant proteins suppress inflammation in autoimmune diseases, promote the differentiation of regulatory T cells and reduce the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/713A61K45/00A61K31/23A61P31/04
CPCA61K31/713A61K45/00A61K31/23A61P31/04Y02A50/30
Inventor 黄钟马艳梅代函鹰叶亮李凌云
Owner 黄钟